Home  |  Contact

Cellosaurus GL261 (CVCL_Y003)

[Text version]

Cell line name GL261
Synonyms Glioma 261; GLIOMA 261; Glioma-261; GL-261
Accession CVCL_Y003
Resource Identification Initiative To cite this cell line use: GL261 (RRID:CVCL_Y003)
Comments Doubling time: ~100-120 hours (DSMZ).
Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
Omics: Cell surface proteome.
Omics: Deep exome analysis.
Omics: HLA class I peptidome analysis by proteomics.
Misspelling: GI261; Occasionally.
Derived from sampling site: Brain.
Disease Mouse glioblastoma (NCIt: C21938)
Species of origin Mus musculus (Mouse) (NCBI Taxonomy: 10090)
Breed/subspecies: C57BL/6.
Hierarchy Children:
CVCL_X986 (GL261-luc2)CVCL_5I93 (GL261-Red-FLuc)CVCL_A5EJ (Quad-GL261)
Category Cancer cell line
Web pages https://en.wikipedia.org/wiki/Glioma_261
Publications

PubMed=16734735; DOI=10.1111/j.1349-7006.2006.00208.x
Szatmari T., Lumniczky K., Desaknai S., Trajcevski S., Hidvegi E.J., Hamada H., Safrany G.
Detailed characterization of the mouse glioma 261 tumor model for experimental glioblastoma therapy.
Cancer Sci. 97:546-553(2006)

PubMed=23248259; DOI=10.4049/jimmunol.1201557
Ohlfest J.R., Andersen B.M., Litterman A.J., Xia J., Pennell C.A., Swier L.E., Salazar A.M., Olin M.R.
Vaccine injection site matters: qualitative and quantitative defects in CD8 T cells primed as a function of proximity to the tumor in a murine glioma model.
J. Immunol. 190:613-620(2013)

PubMed=23686484; DOI=10.4049/jimmunol.1203539
Litterman A.J., Zellmer D.M., Grinnen K.L., Hunt M.A., Dudek A.Z., Salazar A.M., Ohlfest J.R.
Profound impairment of adaptive immune responses by alkylating chemotherapy.
J. Immunol. 190:6259-6268(2013)

PubMed=25894527; DOI=10.1371/journal.pone.0121314
Bausch-Fluck D., Hofmann A., Bock T., Frei A.P., Cerciello F., Jacobs A., Moest H., Omasits U., Gundry R.L., Yoon C., Schiess R., Schmidt A., Mirkowska P., Hartlova A., Van Eyk J.E., Bourquin J.-P., Aebersold R., Boheler K.R., Zandstra P., Wollscheid B.
A mass spectrometric-derived cell surface protein atlas.
PLoS ONE 10:E0121314-E0121314(2015)

PubMed=30084848; DOI=10.1038/sdata.2018.157
Schuster H., Shao W.-G., Weiss T., Pedrioli P.G.A., Roth P., Weller M., Campbell D.S., Deutsch E.W., Moritz R.L., Planz O., Rammensee H.-G., Aebersold R., Caron E.
A tissue-based draft map of the murine MHC class I immunopeptidome.
Sci. Data 5:180157-180157(2018)

PubMed=30524896; DOI=10.1080/2162402X.2018.1501137
Genoud V., Marinari E., Nikolaev S.I., Castle J.C., Bukur V., Dietrich P.-Y., Okada H., Walker P.R.
Responsiveness to anti-PD-1 and anti-CTLA-4 immune checkpoint blockade in SB28 and GL261 mouse glioma models.
OncoImmunology 7:e1501137.1-e1501137.10(2018)

Cross-references
Cell line collections BCRJ; 0299
DSMZ; ACC-802
NCI-DTP; Glioma 261
Other Wikidata; Q27547979
Proteomic databases PRIDE; PXD000589
PRIDE; PXD008733
Entry history
Entry creation05-Sep-2014
Last entry update20-May-2021
Version number10